Gianluca Pirozzi

Direttore/Membro del Consiglio presso TREX WIND-DOWN, INC.

Patrimonio netto: 1 $ in data 31/03/2024

47 anni

Health Technology

Consumer Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Ed Sitar	M	63	TREX WIND-DOWN, INC.	4 anni
Sean Christie	M	-	ALEXION PHARMACEUTICALS, INC.	3 anni
Lubor Gaal	M	56	TREX WIND-DOWN, INC.	4 anni
Piyush Sharma	M	-	ALEXION PHARMACEUTICALS, INC.	7 anni
David Cohen	M	59	TREX WIND-DOWN, INC.	4 anni
Sarah Marshall	F	-	ALEXION PHARMACEUTICALS, INC.	10 anni
Christophe Hotermans	M	-	ALEXION PHARMACEUTICALS, INC.	4 anni
Ruth Diazaraque	M	-	ALEXION PHARMACEUTICALS, INC.	1 anni
Seng Cheng	M	-	ALEXION PHARMACEUTICALS, INC.	1 anni
Jessica Bruno-Raiz	F	-	TREX WIND-DOWN, INC.	5 anni
Glen Frick	M	57	ALEXION PHARMACEUTICALS, INC.	-
Nicola Heffron	F	52	ALEXION PHARMACEUTICALS, INC.	1 anni
Morgan Sanford	F	-	ALEXION PHARMACEUTICALS, INC.	-
Tamar Thompson	F	50	ALEXION PHARMACEUTICALS, INC.	5 anni
Patryk Mikucki	M	49	ALEXION PHARMACEUTICALS, INC.	-
Frédéric Chéreau	M	57	ALEXION PHARMACEUTICALS, INC.	2 anni
Marc Dunoyer	M	71	ALEXION PHARMACEUTICALS, INC.	-
Todd Spalding	M	-	ALEXION PHARMACEUTICALS, INC.	-

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
David Brennan	M	70	ALEXION PHARMACEUTICALS, INC.	7 anni
Zachary Rome	M	40	TREX WIND-DOWN, INC.	2 anni
John Koconis	M	54	TREX WIND-DOWN, INC.	4 anni
Joe Lucchese	M	57	TREX WIND-DOWN, INC.	4 anni
Felix Baker	M	55	ALEXION PHARMACEUTICALS, INC.	6 anni
Rana Strellis	F	-	ALEXION PHARMACEUTICALS, INC.	4 anni
Christopher Coughlin	M	71	ALEXION PHARMACEUTICALS, INC.	7 anni
Susan Altschuller	M	42	ALEXION PHARMACEUTICALS, INC.	2 anni
Michael T. Stocum	M	58	TREX WIND-DOWN, INC.	-
Scott Peters	M	-	ALEXION PHARMACEUTICALS, INC.	8 anni
Michael Ira Kenneth Elloian	M	52	ALEXION PHARMACEUTICALS, INC.	-
Ludwig Hantson	M	61	ALEXION PHARMACEUTICALS, INC.	4 anni
Ebun Garner	M	52	Imbria Pharmaceuticals, Inc. Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA.	1 anni
Jack Mollen	M	73	ALEXION PHARMACEUTICALS, INC.	7 anni
Brian Goff	M	55	ALEXION PHARMACEUTICALS, INC.	4 anni
Judith Reinsdorf	F	60	ALEXION PHARMACEUTICALS, INC.	3 anni
Paul Friedman	M	81	ALEXION PHARMACEUTICALS, INC.	4 anni
Anne-Marie Law	F	56	ALEXION PHARMACEUTICALS, INC.	3 anni
Ellen Chiniara	F	65	ALEXION PHARMACEUTICALS, INC.	3 anni
Francois Nader	M	67	ALEXION PHARMACEUTICALS, INC.	4 anni
Deborah Dunsire	M	61	ALEXION PHARMACEUTICALS, INC.	3 anni
Linda A. Broenniman	F	67	TREX WIND-DOWN, INC.	-
Andreas Rummelt	M	66	ALEXION PHARMACEUTICALS, INC.	11 anni
Thierry Chauche	M	48	ALEXION PHARMACEUTICALS, INC.	1 anni
Ai Min Hui	M	61	Sanofi SA	2 anni
Angela Giannantonio	F	-	ALEXION PHARMACEUTICALS, INC.	-
Shane Doyle	M	-	ALEXION PHARMACEUTICALS, INC.	7 anni
Megan Goulart	F	-	ALEXION PHARMACEUTICALS, INC.	-
Kristen Stants	F	51	ALEXION PHARMACEUTICALS, INC.	2 anni
Adam Hansard	M	48	ALEXION PHARMACEUTICALS, INC.	1 anni
Christopher Wick	M	-	ALEXION PHARMACEUTICALS, INC.	4 anni
Alexandra Kropotova	M	51	Sanofi SA	9 anni
Christopher Sorli	M	-	Sanofi SA	4 anni
Uzair Qadeer	M	-	ALEXION PHARMACEUTICALS, INC.	2 anni
Becky Lillie	F	-	ALEXION PHARMACEUTICALS, INC.	-
Rosemary Harrison	M	41	Imbria Pharmaceuticals, Inc. Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA.	1 anni
Alan Mendelsohn	M	62	TREX WIND-DOWN, INC.	3 anni
Julia Wang	F	53	ALEXION PHARMACEUTICALS, INC.	2 anni
Martine Zimmermann	M	55	ALEXION PHARMACEUTICALS, INC.	7 anni
Holly Schachner	M	57	Sanofi SA	5 anni
Sandra Jonsson	M	51	ALEXION PHARMACEUTICALS, INC.	-
Christopher Benecchi	M	-	ALEXION PHARMACEUTICALS, INC.	2 anni
Michael Lisjak	M	50	Sanofi SA	1 anni
Patrick Barry	M	-	Sanofi SA	24 anni
Ann Miller	M	66	Sanofi SA	6 anni
Amir Tavakkol	M	69	TREX WIND-DOWN, INC.	1 anni
Paul Sekhri	M	65	Sanofi SA	1 anni
Heidi Henson	F	58	Imbria Pharmaceuticals, Inc. Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA.	1 anni
Laurie Keating	F	70	Imbria Pharmaceuticals, Inc. Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA.	1 anni
Christopher J. Stevo	M	-	ALEXION PHARMACEUTICALS, INC.	1 anni
Michael Derby	M	51	TREX WIND-DOWN, INC.	2 anni
Paul Clancy	M	62	ALEXION PHARMACEUTICALS, INC.	2 anni
Emmanuel Babeau	M	57	Sanofi SA	2 anni
Steven M. Bosacki	M	66	TREX WIND-DOWN, INC.	-
Tanisha Cariño	M	49	ALEXION PHARMACEUTICALS, INC.	2 anni
Indrani Franchini	F	52	ALEXION PHARMACEUTICALS, INC.	4 anni
H. Cohen	M	58	Imbria Pharmaceuticals, Inc. Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA.	-
John V. W. Reynders	M	-	ALEXION PHARMACEUTICALS, INC.	6 anni
Vincent O'Neill	M	55	Sanofi SA	2 anni
John Orloff	M	66	ALEXION PHARMACEUTICALS, INC.	4 anni
Dieter Weinand	M	63	Sanofi SA	2 anni
Jose Menoyo	M	-	ALEXION PHARMACEUTICALS, INC.	3 anni
Desiree Luthman	M	65	Sanofi SA	2 anni
Ching Jaw	M	61	Sanofi SA	2 anni
Michael Kaseta	M	48	Sanofi SA	11 anni
Daniel A. Bazarko	M	-	ALEXION PHARMACEUTICALS, INC.	9 anni
Tsveta Milanova	F	47	ALEXION PHARMACEUTICALS, INC.	2 anni
Laura Gault	F	-	ALEXION PHARMACEUTICALS, INC.	3 anni

Statistiche

Paese	Relazioni	% del totale
Stati Uniti	72	83.72%
Francia	14	16.28%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni